Heart and cerebral vessel health monitoring and early warning method and system for old people
Through portable devices, we collect and analyze the physiological parameters and drug administration information of the elderly, build a personalized model, solve the real-time and personalized problems of cardiovascular and cerebrovascular and brain diseases monitoring in the existing technology of middle-aged and elderly people, and realize early warning and Improvement of health management.
Patent Information
- Application Number
- CN202411297878.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-18
- Publication Date
- 2024-12-06
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The existing medical monitoring system is insufficient in real-time and comprehensiveness, making it difficult to effectively monitor cardiovascular and cerebrovascular and brain diseases in the elderly, especially in terms of early warning and personalized medical management, which has failed to meet the special needs of the elderly.
The physiological parameter data and drug administration information of the elderly were collected through portable devices, and pre-processed and personalized model construction was carried out, and the impact of drugs on cardiovascular and cerebrovascular parameters was analyzed in real time, and early warning signals and drug administration feedback reports were generated.
Real-time, comprehensive and personalized monitoring of the cardiovascular and cerebrovascular health status of the elderly has been achieved, early warning capabilities have been improved, acute events have been reduced, and the quality of life and health management of the elderly have been significantly improved.
Smart Images

Figure CN119092041A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of medical health monitoring technology, and in particular to a cardiovascular and cerebrovascular health monitoring and early warning method and system for the elderly. Background Art
[0002] With the aging of the global population, the incidence of cardiovascular and other brain diseases in the elderly population has increased year by year. Brain diseases such as cardiovascular and cerebrovascular diseases and epilepsy are not limited to the cardiovascular system, but may also involve key brain structures such as the amygdala. These diseases are often caused by a variety of complex factors, including genetics, lifestyle and environmental factors. The development of these diseases is not easy to be discovered in time, especially in the elderly population. The progression of the disease may have no obvious warning and is often not identified until an acute attack, such as myocardial infarction or sudden epileptic seizure, seriously threatening life safety.
[0003] Although the existing medical monitoring system can monitor specific physiological parameters to a certain extent, it is still insufficient in terms of real-time and comprehensiveness. For diseases involving cardiovascular and cerebrovascular diseases and brain structures, how to comprehensively evaluate heart rate, blood pressure and the functional status of related brain structures to achieve early warning and disease progression monitoring is a problem that the existing technology urgently needs to solve. In addition, since the elderly's response and metabolism to drugs may be significantly different from those of young people, the existing technology fails to provide enough personalized medical solutions to meet the special needs of the elderly in the management of cardiovascular and cerebrovascular and brain diseases. Therefore, it is particularly necessary to develop a method and system that can monitor cardiovascular and cerebrovascular diseases and brain diseases in the elderly in real time, comprehensively and individually. Summary of the invention
[0004] Based on the above objectives, the present invention provides a cardiovascular health monitoring and early warning method and system for the elderly.
[0005] A cardiovascular health monitoring and early warning method for the elderly population comprises the following steps: S1: collecting physiological parameter data of the elderly through a portable device, the physiological parameters including heart rate, blood pressure, blood oxygen saturation and body temperature, and recording medication information, the medication information including medication name, dosage, taking time and medication type; S2: preprocessing the collected physiological parameter data and drug administration information, wherein the preprocessing includes data noise filtering, outlier removal and data standardization; S3: Based on historical health data, the pharmacological mechanism of the drug and the drug metabolism characteristics, a personalized physiological parameter change model is constructed to simulate the influence trend of the drug on cardiovascular and cerebrovascular physiological parameters; S4: input the real-time physiological parameter data preprocessed in S2 into the physiological parameter change model constructed in S3, analyze the effect of the drug on cardiovascular and cerebrovascular related parameters in real time, and evaluate whether the effect of the drug is within the normal range; S5: When the analysis results of S4 show that the drug has an abnormal effect on physiological parameters, an early warning signal will be automatically generated and a drug administration feedback report will be formed.
[0006] Optionally, the S1 specifically includes: S11: collecting physiological parameters of the elderly through built-in sensors of the portable device, wherein the sensors include sensors for monitoring heart rate, blood pressure, blood oxygen saturation and body temperature, and the device is worn on the wrist of the elderly for monitoring; S12: Processing the collected physiological parameters, converting the heart rate, blood pressure, blood oxygen saturation and body temperature data into standardized values; S13: The portable device records the daily medication information of the elderly through an interface input method or a preset voice input function, wherein the information includes the name of the medication, dosage, taking time and medication type. After the medication information is input, it will be matched and confirmed with the database stored in the device; S14: The collected physiological parameter data and the recorded medication information are transmitted to a remote server for storage via a wireless connection, wherein the wireless connection method includes Bluetooth, Wi-Fi or a cellular network.
[0007] Optionally, the S2 specifically includes: S21: performing data noise filtering on the collected physiological parameter data, specifically using a digital filtering algorithm to remove noise signals in the heart rate, blood pressure, blood oxygen saturation and body temperature data, wherein the digital filtering algorithm includes a low-pass filter and a mean filter; S22: outliers in the data are removed by outlier detection. The outlier detection is based on the comparison between the preset normal range of physiological parameters and the individual historical data. If a value outside the normal range is detected, it is marked as an outlier and removed. S23: standardize the data after noise filtering and outlier removal, and convert the heart rate, blood pressure, blood oxygen saturation and body temperature data into a value range of 0 to 1 using the minimum-maximum standardization method; S24: Perform consistency check on the recorded medication information to ensure that the medication name, dosage, medication time and medication type are consistent with the records in the database.
[0008] Optionally, the S3 specifically includes: S31: Collect and organize the historical health data of the elderly, wherein the historical health data includes the individual's physiological parameter change trend, past medical history, drug use record and past monitoring data; S32: Classify the influencing factors of each drug according to its pharmacological mechanism. Specifically, define the direct or indirect effects of the drug on heart rate, blood pressure, blood oxygen saturation and body temperature through known pharmacological data, and classify and calibrate them; S33: Based on the metabolic characteristics of drugs, calculate the metabolic rate of drugs in the elderly, combine the individual's age, weight, liver and kidney function parameters, and use drug metabolism models to estimate the half-life of drugs and the continuous effects on physiological parameters; S34: Combining historical health data, the pharmacological mechanism of action and metabolic characteristics of the drug, a personalized physiological parameter change model is constructed using a multivariate regression analysis algorithm. The multivariate regression analysis inputs variables such as drug dosage, drug half-life, and individual health data to analyze the effects of these variables on heart rate, blood pressure, blood oxygen saturation, and body temperature, and the model is trained by fitting actual data; S35: Check the model and verify it using the collected data on changes in physiological parameters of the elderly. If the predicted result deviates greatly from the actual change, the personalized physiological parameter change model is optimized by adjusting the regression weights.
[0009] Optionally, the S34 specifically includes: S341: Based on the pharmacological mechanism and metabolic characteristics of the drug, define the key variables that affect physiological parameters as drug dosage , Drug Half-Life , the age of the individual ,weight , heart rate ,blood pressure , blood oxygen saturation and body temperature ; S342: Using a multivariate regression analysis algorithm, construct a personalized physiological parameter change model, wherein the expression of the personalized physiological parameter change model is: ,in, Indicates the change value of the target physiological parameter, is a constant term, to is the regression coefficient of each variable, is the error term, which is used to reflect the deviation between the model prediction value and the actual value; S343: Fit the model with historical data and use the least squares method to estimate the optimal value of each regression coefficient.
[0010] Optionally, the S35 specifically includes: S351: Use the collected data on changes in physiological parameters of the elderly to verify the constructed personalized physiological parameter change model and calculate the model prediction value Changes in actual physiological parameters The Difference ; S352: According to the difference Calculate the mean square error of the model to evaluate the overall accuracy of the model; S353: When the mean square error exceeds the preset threshold, it indicates that the model prediction error is large, indicating that the weight coefficient of the regression model needs to be optimized; S354: The regression weight coefficient is adjusted through multiple iterations to gradually reduce the prediction error until the mean square error is lower than a preset threshold.
[0011] Optionally, the S4 specifically includes: S41: Set the preprocessed real-time physiological parameters in S2 to , and Input into the personalized physiological parameter change model constructed in S3 for calculation, and output the predicted physiological parameter change value ; S42: Output the predicted physiological parameter change value by comparison Real-time measured physiological parameter values , calculate the difference ; S43: Prediction difference Variation range with preset normal physiological parameters For comparison, if , then the drug effect is judged to be within the normal range; if , then the drug is considered to have an abnormal effect on physiological parameters.
[0012] Optionally, the S5 specifically includes: S51: When the analysis result of S4 shows that the drug has an abnormal effect on the physiological parameters, an early warning signal is automatically generated, and the early warning signal is triggered by an internal judgment mechanism, and the judgment mechanism is used to be activated when the magnitude of the drug's effect on the physiological parameters exceeds a preset safety threshold; S52: The generated warning signal is transmitted in real time to the mobile terminal of the user, family members and attending physician via wireless communication technology; S53: After the warning signal is generated, a drug administration feedback report is automatically generated, and the report content includes abnormal physiological parameters, drug name, dosage, administration time and analysis results of abnormal physiological reactions; S54: The medication feedback report will be automatically stored in the user's personal health record and uploaded to the cloud health monitoring platform for users, doctors and related medical personnel to review at any time.
[0013] Optionally, the wireless communication technology in S52 includes mobile phone push notification, text message and email.
[0014] A cardiovascular and cerebrovascular health monitoring and early warning system for the elderly population, used to implement the above-mentioned cardiovascular and cerebrovascular health monitoring and early warning method for the elderly population, includes the following modules: Data acquisition module: used to collect physiological parameter data of the elderly in real time through portable devices, the physiological parameters include heart rate, blood pressure, blood oxygen saturation and body temperature, and record medication information, the medication information includes medication name, dosage, taking time and medication type; Data preprocessing module: connected to the data acquisition module, used to filter noise, remove abnormal values and perform data standardization on the collected physiological parameter data and drug administration information; Personalized model building module: Based on the historical health data, pharmacological action mechanism and metabolic characteristics of drugs provided by the data preprocessing module, a personalized physiological parameter change model is built to predict the dynamic effects of drugs on cardiovascular and cerebrovascular related physiological parameters; Real-time analysis module: connected to the personalized model building module, used to input the pre-processed real-time physiological parameter data into the personalized model, analyze the effect of drugs on the cardiovascular and cerebrovascular health of the elderly in real time, and determine whether its effect is within the normal range; Warning generation module: When the analysis results of the real-time analysis module show that the drug has an abnormal effect on physiological parameters, a warning signal is automatically generated; Report generation module: connected to the early warning generation module, used to generate a drug intake feedback report after the early warning signal is generated. The feedback report includes abnormal physiological parameters, drug name, dosage, intake time and analysis results of abnormal physiological reactions, and is stored in the cloud health monitoring platform.
[0015] Beneficial effects of the present invention: The present invention can effectively monitor the cardiovascular health status by real-time collection and analysis of the physiological parameters and medication information of the elderly, and improve the early warning capability of cardiovascular and cerebrovascular and brain diseases by combining the functional changes of brain structures such as the amygdala. The accuracy of the data is ensured through precise preprocessing technology, and the personalized physiological parameter change model is used, combined with the pharmacological action mechanism and metabolic characteristics of the drug, to achieve accurate prediction of the effect of the drug on cardiovascular and cerebrovascular and brain functions, thereby providing personalized health management solutions for the elderly.
[0016] The present invention, through the intelligent early warning mechanism, the system can generate early warning signals and feedback reports in time when potential risks related to cardiovascular and cerebrovascular abnormalities or brain diseases such as epilepsy are detected, and effectively notify medical personnel and patients' families. This technology greatly improves the prevention ability of brain and cardiovascular and cerebrovascular diseases in the elderly, reduces the occurrence of acute events, and significantly improves the quality of life and health management level of the elderly. BRIEF DESCRIPTION OF THE DRAWINGS
[0017] In order to more clearly illustrate the technical solutions in the present invention or the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings in the following description are only for the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0018] Figure 1 A schematic diagram of a cardiovascular and cerebrovascular health monitoring and early warning method according to an embodiment of the present invention; Figure 2 Schematic diagram of a cardiovascular and cerebrovascular health monitoring and early warning system according to an embodiment of the present invention. DETAILED DESCRIPTION
[0019] The present invention is described in detail below in conjunction with the accompanying drawings and specific embodiments. At the same time, it is explained here that in order to make the embodiments more detailed, the following embodiments are the best and preferred embodiments, and those skilled in the art may also adopt other alternatives to implement some known technologies; and the accompanying drawings are only for more specific description of the embodiments, and are not intended to specifically limit the present invention.
[0020] It should be noted that the references to "one embodiment", "embodiment", "exemplary embodiments", "some embodiments" and the like in the specification indicate that the embodiments described may include specific features, structures or characteristics, but not every embodiment may include the specific features, structures or characteristics. In addition, when a specific feature, structure or characteristic is described in conjunction with an embodiment, it should be within the knowledge of a person skilled in the art to implement such feature, structure or characteristic in conjunction with other embodiments (whether or not explicitly described).
[0021] In general, a term can be understood, at least in part, from its use in context. For example, depending, at least in part, on the context, the term "one or more" as used herein can be used to describe any feature, structure, or characteristic in the singular sense, or can be used to describe a combination of features, structures, or characteristics in the plural sense. Additionally, the term "based on" can be understood as not necessarily intended to convey an exclusive set of factors, but can instead, depending, at least in part, on the context, allow for the presence of other factors that are not necessarily explicitly described.
[0022] like Figure 1As shown, a cardiovascular health monitoring and early warning method for the elderly population includes the following steps: S1: The physiological parameter data of the elderly are collected through portable devices. The physiological parameters include heart rate, blood pressure, blood oxygen saturation and body temperature. At the same time, the medication information is recorded. The medication information includes the name of the drug, dosage, time of taking and the type of medication. S2: Preprocess the collected physiological parameter data and drug administration information, including data noise filtering, outlier removal and data standardization to ensure data accuracy and consistency; S3: Based on historical health data, the pharmacological mechanism of the drug and the drug metabolism characteristics, a personalized physiological parameter change model is constructed to simulate the influence trend of the drug on cardiovascular and cerebrovascular physiological parameters; S4: input the real-time physiological parameter data preprocessed in S2 into the physiological parameter change model constructed in S3, analyze the effect of the drug on cardiovascular and cerebrovascular related parameters in real time, and evaluate whether the effect of the drug is within the normal range; S5: When the analysis results of S4 show that the drug has an abnormal effect on physiological parameters, such as abnormal fluctuations in heart rate or blood pressure exceeding the safety threshold set by the model, an early warning signal will be automatically generated and a drug intake feedback report will be formed. The report content includes abnormal physiological parameters, drug name, dosage and recommended adjustment plan.
[0023] S1 specifically includes: S11: The physiological parameters of the elderly are collected through the built-in sensors of the portable device, including sensors for monitoring heart rate, blood pressure, blood oxygen saturation and body temperature. The device is worn on the wrist of the elderly for monitoring; S12: Process the collected physiological parameters and convert the heart rate, blood pressure, blood oxygen saturation and body temperature data into standardized values to ensure data consistency; S13: The portable device records the elderly person's daily medication information through an interface input method or a preset voice input function, the information including the name of the medication, dosage, taking time and medication type. After the medication information is input, it will be matched and confirmed with a database stored in the device; S14: The collected physiological parameter data and recorded medication information are transmitted to a remote server via a wireless connection for storage to ensure real-time data transmission and synchronization. The wireless connection methods include Bluetooth, Wi-Fi or cellular networks. Through the above steps, the portable device can effectively collect multiple physiological parameters of the elderly and record medication information in a timely manner. Data processing and transmission ensure the accuracy and timeliness of health monitoring. This method not only improves monitoring efficiency, but also provides reliable data support for drug impact analysis.
[0024] The preprocessing in S2 specifically includes: S21: filtering the collected physiological parameter data for data noise, specifically using a digital filtering algorithm to remove noise signals in the heart rate, blood pressure, blood oxygen saturation and body temperature data. The digital filtering algorithm includes a low-pass filter and a mean filter, which are used to eliminate interference signals introduced by unstable wearing of the device or environmental factors; S22: outliers in the data are removed by outlier detection. The outlier detection is based on the comparison between the preset normal range of physiological parameters and the individual historical data. If a value outside the normal range is detected, it is marked as an outlier and removed. S23: After noise filtering and outlier removal, the data were normalized and the heart rate, blood pressure, blood oxygen saturation and body temperature data were converted to a value range of 0 to 1 using the minimum-maximum normalization method to ensure the comparability of data at different time points and between different individuals; S24: Perform consistency check on the recorded medication information to ensure that the medication name, dosage, medication time and medication type are consistent with the records in the database. If any inconsistency is found, correct or supplement it. Through the above steps, the collected physiological parameter data and medication information are fully pre-processed before being uploaded to the health monitoring platform to ensure the accuracy, stability and consistency of the data, providing a reliable basis for subsequent health assessment and drug impact analysis.
[0025] S3 specifically includes: S31: Collect and organize the historical health data of the elderly, including the trend of changes in individual physiological parameters, previous medical history, drug use records and previous monitoring data, to ensure the integrity and consistency of the data; S32: Classify the influencing factors of each drug according to its pharmacological mechanism. Specifically, define the direct or indirect effects of the drug on heart rate, blood pressure, blood oxygen saturation and body temperature through known pharmacological data, and classify and calibrate them; The following specific steps are defined in S32: S321: Based on known pharmacological data, define the direct or indirect effects of the drug on heart rate, blood pressure, blood oxygen saturation and body temperature. The direct effects of the drug are quantified by its target, as follows: - The heart rate-lowering effect of beta-blockers; S322: The direct effect of a drug is defined by the following formula: ,in, Indicates the effect of the drug on the heart rate. is the basal heart rate when not taking medication, is the effect coefficient of the drug on heart rate, is the dose of the drug taken; S323: The direct impact on other physiological parameters is also defined by a similar formula, such as the impact on blood pressure: ,in, Indicates the effect of the drug on blood pressure. is the baseline blood pressure value when not taking medication. is the effect coefficient of the drug on blood pressure, for the dosage of the drug; S324: The indirect effects of drugs are defined by the interaction with other physiological parameters as follows: ,in, Indicates the indirect effect of blood pressure changes on heart rate, is the influence coefficient of blood pressure change on heart rate, is the current blood pressure value, is the standard blood pressure value; S325: Based on the above formula, construct the influence function of the drug on each physiological parameter, and classify and calibrate the direct and indirect effects of the drug. The direct effects are calibrated through the drug target effects, and the indirect effects are classified through the interaction effects between physiological parameters. The final influence function is used for subsequent model construction and predictive analysis in health monitoring.
[0026] S33: Based on the metabolic characteristics of drugs, calculate the metabolic rate of drugs in the elderly, combine the individual's age, weight, liver and kidney function parameters, and use drug metabolism models to estimate the half-life of drugs and the continuous effects on physiological parameters; The specific steps for calculating the metabolic rate of drugs in the elderly are as follows: S331: Determine the metabolic rate of drugs in the elderly based on their pharmacokinetic properties. The metabolic rate of drugs is mainly affected by individual factors such as liver and kidney function, age, and body weight; S332: The metabolic rate of a drug is calculated using the following formula: ,in, is the drug metabolism rate constant, represents the total clearance of the drug, It indicates the distribution volume of the drug in the body; S333: Total clearance of the drug It is determined by the clearance rates of the liver and kidneys, which can be expressed by the following formula: ,in, is the liver clearance rate, is the renal clearance rate, both of which are affected by the individual's liver and kidney function; S334: Volume of distribution of drugs in the body According to the individual's weight and age, the formula is as follows: ,in, is the total dose of the drug, is the concentration of the drug in plasma; S335: The metabolic rate constant calculated by combining the above formula , the half-life of the drug It is obtained by the following formula: , half-life reflects the metabolism time of the drug in the elderly, helping to evaluate the drug's sustained impact and duration of action on physiological parameters; through these steps, the drug's metabolic rate can be accurately calculated based on individual characteristics such as liver and kidney function, weight and age, ensuring personalized evaluation of the drug's metabolic process and providing a scientific basis for predicting the dynamic effects of drugs on the physiological parameters of the elderly.
[0027] S34: Combine historical health data, the pharmacological mechanism of the drug and the metabolic characteristics, and use the multivariate regression analysis algorithm to build a personalized physiological parameter change model. The multivariate regression analysis inputs variables such as drug dose, drug half-life, and individual health data to analyze the impact of these variables on heart rate, blood pressure, blood oxygen saturation, and body temperature, and trains the model by fitting actual data; S35: Check the model and verify it using the collected data on changes in physiological parameters of the elderly. If the predicted results deviate greatly from the actual changes, the personalized physiological parameter change model is optimized by adjusting the regression weights to ensure that it can accurately predict the effects of drugs on physiological parameters.
[0028] The personalized physiological parameter change model constructed in S34 specifically includes: S341: Based on the pharmacological mechanism and metabolic characteristics of the drug, define the key variables that affect physiological parameters as drug dosage , Drug Half-Life , the age of the individual ,weight , heart rate ,blood pressure , blood oxygen saturation and body temperature ; S342: Using a multivariate regression analysis algorithm, construct a personalized physiological parameter change model. The expression of the personalized physiological parameter change model is: ,in, Indicates the change value of target physiological parameters (such as heart rate, blood pressure, etc.). is a constant term, to is the regression coefficient of each variable, is the error term, which is used to reflect the deviation between the model prediction value and the actual value; S343: Fit the model with historical data and estimate the regression coefficients using the least squares method The optimal value of is: ,in, is the input variable matrix, including drug dosage, half-life, age, weight, etc. is the change value of the target physiological parameter, is the estimated regression coefficient.
[0029] S35 specifically includes: S351: Use the collected data on changes in physiological parameters of the elderly to verify the constructed personalized physiological parameter change model and calculate the model prediction value Changes in actual physiological parameters The Difference , the difference is calculated by the following formula: in, is the difference between the actual value and the predicted value, is the actual measured change value of physiological parameters, is the change value of physiological parameters predicted by the model; S352: According to the difference Calculate the mean square error of the model to evaluate the overall accuracy of the model. The formula is: ,in, is the mean square error, is the sample size, For the The predicted difference value of samples; S353: When the mean square error exceeds the preset threshold, it indicates that the model prediction error is large, indicating that the weight coefficient of the regression model needs to be adjusted. Optimize by adjusting the weight coefficient through the gradient descent algorithm. The optimization formula is as follows: ,in, is the optimized regression weight, is the weight before optimization, is the learning rate, is the mean square error with respect to weight The gradient of S354: The prediction error is gradually reduced by iteratively adjusting the regression weight coefficient until the mean square error is lower than the preset threshold, ensuring that the prediction results of the model are consistent with the actual physiological parameter change values; through the above steps, the personalized physiological parameter change model is verified using the collected physiological parameter change data of the elderly, and the regression weight is optimized through the gradient descent algorithm, which can effectively reduce the prediction error, improve the accuracy and stability of the model, and ensure that the health monitoring and early warning results are more reliable.
[0030] S4 specifically includes: S41: Set the preprocessed real-time physiological parameters in S2 to , including heart rate ,blood pressure , blood oxygen saturation ,body temperature etc. and will Input into the personalized physiological parameter change model constructed in S3 for calculation, and output the predicted physiological parameter change value , the model predicts the effect of drugs on various physiological parameters through the following formula: ,in, is the change value of physiological parameters predicted by the model, and the input variables include drug dosage , Drug Half-Life ,age ,weight and other real-time physiological parameters; S42: Output the predicted physiological parameter change value by comparison Real-time measured physiological parameter values , calculate the difference , the formula is, , to determine whether the actual impact of the drug action exceeds the expected range; S43: Prediction difference Variation range with preset normal physiological parameters For comparison, if , then the drug effect is judged to be within the normal range; if , it is considered that the drug has an abnormal effect on the physiological parameters; through the above steps, the impact of the drug on cardiovascular and cerebrovascular related parameters is analyzed in real time, and by comparing the predicted difference with the normal range, it can be accurately judged whether the drug effect is within an acceptable range, ensuring that the monitoring of the health of the elderly is timely and effective.
[0031] S5 specifically includes: S51: When the analysis result of S4 shows that the drug has an abnormal effect on the physiological parameters, an early warning signal will be automatically generated. The early warning signal is triggered by an internal judgment mechanism. The judgment mechanism is used to start when the magnitude of the drug's effect on the physiological parameters exceeds a preset safety threshold; S52: The generated warning signal is transmitted in real time to the mobile terminals of the user, family members and attending physicians through wireless communication technology, ensuring that the warning information can be conveyed to relevant personnel in the shortest possible time; S53: After the early warning signal is generated, a drug taking feedback report is automatically generated, which includes abnormal physiological parameters, drug name, dosage, taking time and analysis results of abnormal physiological reactions. The report will record in detail the impact of drug taking on the physiological changes of the elderly; S54: The medication feedback report will be automatically stored in the user's personal health record and uploaded to the cloud health monitoring platform for users, doctors and related medical personnel to review at any time, so as to be used as a reference for the next medication adjustment or doctor's evaluation; through the above steps, the system can automatically generate a warning signal when it detects that the drug has an abnormal effect on physiological parameters, and form a detailed medication feedback report, realizing real-time monitoring and automated processing of drug effects, ensuring that the health status of the elderly is intervened and managed in a timely manner.
[0032] Wireless communication technologies in S52 include mobile phone push notifications, text messages and emails.
[0033] like Figure 2 As shown, a cardiovascular and cerebrovascular health monitoring and early warning system for the elderly is used to implement the above-mentioned cardiovascular and cerebrovascular health monitoring and early warning method for the elderly, including the following modules: Data acquisition module: used to collect physiological parameter data of the elderly in real time through portable devices. Physiological parameters include heart rate, blood pressure, blood oxygen saturation and body temperature, and record medication information. Medication information includes drug name, dosage, taking time and drug type; Data preprocessing module: connected to the data acquisition module, used to filter noise, remove outliers and standardize data for the collected physiological parameter data and drug administration information to ensure the accuracy and consistency of the data; Personalized model building module: Based on the historical health data, pharmacological action mechanism and metabolic characteristics of drugs provided by the data preprocessing module, a personalized physiological parameter change model is built to predict the dynamic effects of drugs on cardiovascular and cerebrovascular related physiological parameters; Real-time analysis module: connected to the personalized model building module, used to input the pre-processed real-time physiological parameter data into the personalized model, analyze the effect of drugs on the cardiovascular and cerebrovascular health of the elderly in real time, and determine whether its effect is within the normal range; Warning generation module: When the analysis results of the real-time analysis module show that the drug has an abnormal effect on physiological parameters, a warning signal is automatically generated and transmitted to the user, family members and doctors through communication; Report generation module: connected to the early warning generation module, used to generate a medication feedback report after the early warning signal is generated. The feedback report includes abnormal physiological parameters, drug name, dosage, taking time and analysis results of abnormal physiological reactions, and is stored on the cloud health monitoring platform.
[0034] The present invention covers any substitution, modification, equivalent method and scheme made on the essence and scope of the present invention. In order to make the public have a thorough understanding of the present invention, specific details are described in detail in the following preferred embodiments of the present invention, but those skilled in the art can fully understand the present invention without the description of these details. In addition, in order to avoid unnecessary confusion about the essence of the present invention, well-known methods, processes, procedures, components and circuits are not described in detail.
[0035] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.
Claims
1. A cardiovascular health monitoring and early warning method for the elderly, characterized in that: The following steps are involved: S1: collecting physiological parameter data of the elderly through a portable device, the physiological parameters including heart rate, blood pressure, blood oxygen saturation and body temperature, and recording medication information, the medication information including medication name, dosage, taking time and medication type; S2: preprocessing the collected physiological parameter data and drug administration information, wherein the preprocessing includes data noise filtering, outlier removal and data standardization; S3: Based on historical health data, the pharmacological mechanism of the drug and the drug metabolism characteristics, a personalized physiological parameter change model is constructed to simulate the influence trend of the drug on cardiovascular and cerebrovascular physiological parameters; S4: input the real-time physiological parameter data preprocessed in S2 into the physiological parameter change model constructed in S3, analyze the effect of the drug on cardiovascular and cerebrovascular related parameters in real time, and evaluate whether the effect of the drug is within the normal range; S5: When the analysis results of S4 show that the drug has an abnormal effect on physiological parameters, an early warning signal will be automatically generated and a drug administration feedback report will be formed.
2. The cardiovascular health monitoring and early warning method for the elderly according to claim 1 is characterized in that: The S1 specifically includes: S11: collecting physiological parameters of the elderly through built-in sensors of the portable device, wherein the sensors include sensors for monitoring heart rate, blood pressure, blood oxygen saturation and body temperature, and the device is worn on the wrist of the elderly for monitoring; S12: Processing the collected physiological parameters, converting the heart rate, blood pressure, blood oxygen saturation and body temperature data into standardized values; S13: The portable device records the daily medication information of the elderly through an interface input method or a preset voice input function, wherein the information includes the name of the medication, dosage, taking time and medication type. After the medication information is input, it will be matched and confirmed with the database stored in the device; S14: The collected physiological parameter data and the recorded medication information are transmitted to a remote server for storage via a wireless connection, wherein the wireless connection method includes Bluetooth, Wi-Fi or a cellular network.
3. The cardiovascular health monitoring and early warning method for the elderly according to claim 1 is characterized in that: The S2 specifically includes: S21: performing data noise filtering on the collected physiological parameter data, specifically using a digital filtering algorithm to remove noise signals in the heart rate, blood pressure, blood oxygen saturation and body temperature data, wherein the digital filtering algorithm includes a low-pass filter and a mean filter; S22: outliers in the data are removed by outlier detection. The outlier detection is based on the comparison between the preset normal range of physiological parameters and the individual historical data. If a value outside the normal range is detected, it is marked as an outlier and removed. S23: standardize the data after noise filtering and outlier removal, and convert the heart rate, blood pressure, blood oxygen saturation and body temperature data into a value range of 0 to 1 using the minimum-maximum standardization method; S24: Perform consistency check on the recorded medication information to ensure that the medication name, dosage, medication time and medication type are consistent with the records in the database.
4. The cardiovascular health monitoring and early warning method for the elderly according to claim 1, characterized in that: The S3 specifically includes: S31: Collect and organize the historical health data of the elderly, wherein the historical health data includes the individual's physiological parameter change trend, past medical history, drug use record and past monitoring data; S32: Classify the influencing factors of each drug according to its pharmacological mechanism. Specifically, define the direct or indirect effects of the drug on heart rate, blood pressure, blood oxygen saturation and body temperature through known pharmacological data, and classify and calibrate them; S33: Based on the metabolic characteristics of drugs, calculate the metabolic rate of drugs in the elderly, combine the individual's age, weight, liver and kidney function parameters, and use drug metabolism models to estimate the half-life of drugs and the continuous effects on physiological parameters; S34: Combining historical health data, the pharmacological mechanism of action and metabolic characteristics of the drug, a personalized physiological parameter change model is constructed using a multivariate regression analysis algorithm. The multivariate regression analysis inputs variables such as drug dosage, drug half-life, and individual health data to analyze the effects of these variables on heart rate, blood pressure, blood oxygen saturation, and body temperature, and the model is trained by fitting actual data; S35: Check the model and verify it using the collected data on changes in physiological parameters of the elderly. If the predicted result deviates greatly from the actual change, the personalized physiological parameter change model is optimized by adjusting the regression weights.
5. The cardiovascular health monitoring and early warning method for the elderly according to claim 4, characterized in that: The S34 specifically includes: S341: Based on the pharmacological mechanism and metabolic characteristics of the drug, define the key variables that affect physiological parameters as drug dosage , Drug Half-Life , the age of the individual ,weight , heart rate ,blood pressure , blood oxygen saturation and body temperature ; S342: Using a multivariate regression analysis algorithm, construct a personalized physiological parameter change model, wherein the expression of the personalized physiological parameter change model is: ,in, Indicates the change value of the target physiological parameter, is a constant term, to is the regression coefficient of each variable, is the error term, which is used to reflect the deviation between the model prediction value and the actual value; S343: Fit the model with historical data and use the least squares method to estimate the optimal value of each regression coefficient.
6. The cardiovascular health monitoring and early warning method for the elderly according to claim 5, characterized in that: The S35 specifically includes: S351: Use the collected data on changes in physiological parameters of the elderly to verify the constructed personalized physiological parameter change model and calculate the model prediction value Changes in actual physiological parameters The Difference ; S352: According to the difference Calculate the mean square error of the model to evaluate the overall accuracy of the model; S353: When the mean square error exceeds the preset threshold, it indicates that the model prediction error is large, indicating that the weight coefficient of the regression model needs to be optimized; S354: The regression weight coefficient is adjusted through multiple iterations to gradually reduce the prediction error until the mean square error is lower than a preset threshold.
7. The cardiovascular health monitoring and early warning method for the elderly according to claim 1, characterized in that: The S4 specifically includes: S41: Set the preprocessed real-time physiological parameters in S2 to , and Input into the personalized physiological parameter change model constructed in S3 for calculation, and output the predicted physiological parameter change value ; S42: Output the predicted physiological parameter change value by comparison Real-time measured physiological parameter values , calculate the difference ; S43: Prediction difference Variation range with preset normal physiological parameters For comparison, if , then the drug effect is judged to be within the normal range; if , then the drug is considered to have an abnormal effect on physiological parameters.
8. The cardiovascular and cerebrovascular health monitoring and early warning method for the elderly according to claim 1, characterized in that: The S5 specifically includes: S51: When the analysis result of S4 shows that the drug has an abnormal effect on the physiological parameters, an early warning signal is automatically generated, and the early warning signal is triggered by an internal judgment mechanism, and the judgment mechanism is used to be activated when the magnitude of the drug's effect on the physiological parameters exceeds a preset safety threshold; S52: The generated warning signal is transmitted in real time to the mobile terminal of the user, family members and attending physician via wireless communication technology; S53: After the warning signal is generated, a drug administration feedback report is automatically generated, and the report content includes abnormal physiological parameters, drug name, dosage, administration time and analysis results of abnormal physiological reactions; S54: The medication feedback report will be automatically stored in the user's personal health record and uploaded to the cloud health monitoring platform for users, doctors and related medical personnel to review at any time.
9. The cardiovascular health monitoring and early warning method for the elderly according to claim 8, characterized in that: The wireless communication technology in S52 includes mobile phone push notification, text message and email.
10. A cardiovascular and cerebrovascular health monitoring and early warning system for the elderly, used to implement the cardiovascular and cerebrovascular health monitoring and early warning method for the elderly as claimed in any one of claims 1 to 9, characterized in that: Includes the following modules: Data acquisition module: used to collect physiological parameter data of the elderly in real time through portable devices, the physiological parameters include heart rate, blood pressure, blood oxygen saturation and body temperature, and record medication information, the medication information includes medication name, dosage, taking time and medication type; Data preprocessing module: connected to the data acquisition module, used to filter noise, remove abnormal values and perform data standardization on the collected physiological parameter data and drug administration information; Personalized model building module: Based on the historical health data, pharmacological action mechanism and metabolic characteristics of drugs provided by the data preprocessing module, a personalized physiological parameter change model is built to predict the dynamic effects of drugs on cardiovascular and cerebrovascular related physiological parameters; Real-time analysis module: connected to the personalized model building module, used to input the pre-processed real-time physiological parameter data into the personalized model, analyze the effect of drugs on the cardiovascular and cerebrovascular health of the elderly in real time, and determine whether its effect is within the normal range; Warning generation module: When the analysis results of the real-time analysis module show that the drug has an abnormal effect on physiological parameters, a warning signal is automatically generated; Report generation module: connected to the early warning generation module, used to generate a drug intake feedback report after the early warning signal is generated. The feedback report includes abnormal physiological parameters, drug name, dosage, intake time and analysis results of abnormal physiological reactions, and is stored in the cloud health monitoring platform.
Citation Information
Patent Citations
Hypertensive patient health management system
CN114898841A
Medication prediction method and system and medication nursing device
CN116741406A
Health guidance method and system for hypertensive patients
CN117198513A
Rehabilitation nursing remote cooperation method and system
CN117936020A
Medical equipment management system and method based on data analysis
CN117976125A
Cited By
AI-based postoperative rehabilitation nursing system and method for old people
CN119296716A
Management system for oral medicine of stroke patient based on AI smart bracelet
CN119889569A
Production line capacity intelligent management method for pharmaceutical production
CN119962937A
Data analysis-based senile chronic disease judgment method and system
CN120148864A
Method and system for judging chronic diseases in the elderly based on data analysis
CN120148864B
